Lineage Cell Therapeutics, Inc.

Ownership Transactions Reported by 15 Insiders

Symbol
LCTX on NYSE
Industry
Biological Products, (No Diagnostic Substances)
Location
2173 Salk Avenue, Suite 200, Carlsbad, CA

Insiders trading volume in the past year

Lineage Cell Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Broadwood Partners, L.P. Director, 10%+ Owner $75.3M +$6M +8.65% Jan 27, 2025
Alfred D. Kingsley Chairman, Director $7.47M Jul 1, 2023
Michael H. Mulroy Director $169K +$22.6K +15.5% Jul 1, 2025
Don M. Bailey Director $165K Jul 1, 2024
Brian M. Culley President and CEO, Director $139K +$24K +20.9% Mar 10, 2025
Neal C. Bradsher Director, 10%+ Owner $36K Jul 1, 2025
George A. Samuel III General Counsel and Secretary $16.8K +$9K +116% Mar 10, 2025
Jill A. Howe Chief Financial Officer $15K +$8.85K +143% Mar 10, 2025
Gary S. Hogge SVP,Clinical & Medical Affairs $8.4K Mar 9, 2023
Dipti Amin Director Jul 1, 2025
Angus C. Russell Director Jul 1, 2025
Deborah J. Andrews Director Jul 1, 2025
Alexandra Hernandez Sr Director Finance/Controller Jul 7, 2022
Anula Jayasuriya Director Jul 1, 2025
Kevin Leon Cook Chief Financial Officer Mar 10, 2022

Recent Insider Transactions by Companies or Individuals for Lineage Cell Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.